Latest news from QuadroPharma and our brand portfolio. For media enquiries, contact our communications team.
QuadroPharma announced the expansion of its UAE-entity distribution partnerships to cover 15 new international markets across Southeast Asia, MENA, and Sub-Saharan Africa.
Building on a strong UK retail performance, ETERNIA Wellness has confirmed distribution partnerships with two leading European health retailers covering Germany, the Netherlands, and Scandinavia.
ETRNL Longevity has launched its most comprehensive formulation to date — a four-product Cellular Energy Stack targeting mitochondrial function, NAD+ support, and hormonal optimisation.
QuadroPharma has received simultaneous ISO 22000 food safety management and HACCP certification across its primary US manufacturing facility, completing the full compliance stack.
FOY Labs has entered the Gulf Cooperation Council markets with its full premium botanical wellness range, distributed through established pharmacy and lifestyle retail channels in the UAE, Saudi Arabia, and Kuwait.
Full brand asset packs — including high-resolution logos, brand guidelines, and approved photography — are available to accredited media and distribution partners.
Corporate news, executive interviews, and company-wide enquiries
ETERNIA, ETRNL, and FOY brand-specific media enquiries and product reviews
QuadroPharma is a pharmaceutical and nutraceutical company with an expanding portfolio spanning branded API development, consumer brands, men's health, contract manufacturing, and strategic partnerships. Its international network connects USA manufacturing, a London-based European marketing and business development presence, and UAE distribution. Its brand portfolio includes IMMANX, ETERNIA Wellness, ETRNL Longevity, and FOY Labs.